Merck Witness' Omission Leads To New Vioxx Trial
In a blow to Merck & Co., a federal judge has granted one of the Vioxx plaintiffs a new trial after ruling that a key witness for the pharmaceutical giant misrepresented...To view the full article, register now.
Already a subscriber? Click here to view full article